Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSummit Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2024 | 3 | -$0.07 | -$0.06 | -$0.06 |
| Q1 2025 | 2 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q1 2026 | 1 | -$0.64 | -$0.64 | -$0.64 |
Summit Therapeutics Inc. Earnings Date And Information
Summit Therapeutics Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Summit Therapeutics Inc. has generated $-1 earnings per share over the last year ($-0.99 diluted earnings per share) and currently has a price-to-earnings ratio of -66.02. Summit Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
Summit Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2024 | Q3 2024 | -$0.07 | -$0.08 | -0.01 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.06 | -$0.09 | -0.03 | $0 | $0 |
| 05/01/2024 | Q1 2024 | -$0.06 | -$0.06 | -0 | $0 | |
| 02/20/2024 | Q4 2023 | -$0.05 | $-235,000 | |||
| 11/07/2023 | Q3 2023 | -$0.03 | $0 | |||
| 08/09/2023 | Q2 2023 | -$0.02 | $235,000 | |||
| 05/11/2023 | Q1 2023 | -$4.18 | $0 | |||
| 03/09/2023 | Q4 2022 | -$0.26 | -$0.08 | 0.18 | $705 | |
| 11/09/2022 | Q3 2022 | -$0.26 | -$0.17 | 0.09 | $220,000 | |
| 08/11/2022 | Q2 2022 | -$0.12 | $235,000 | |||
| 05/11/2022 | Q1 2022 | -$0.21 | $250,000 | |||
| 03/17/2022 | Q4 2021 | -$0.28 | $251,000 | |||
| 11/15/2021 | Q3 2021 | -$0.29 | -$0.20 | 0.09 | $1.31 M | |
| 08/12/2021 | Q2 2021 | -$0.27 | $3.22 M | $57,000 | ||
| 05/17/2021 | Q1 2021 | -$0.21 | $192,000 | |||
| 03/31/2021 | Q4 2020 | -$0.18 | $185,000 | |||
| 11/16/2020 | Q3 2020 | -$0.01 | -$0.26 | -0.25 | $3.16 M | $181,000 |
| 06/30/2020 | Q2 2020 | -$0.23 | $3.21 M | $170,000 | ||
| 03/31/2020 | Q1 2020 | -$0.11 | $386,291 | |||
| 04/30/2020 | Q4 2019 | -$0.19 | $9,140 |
Summit Therapeutics Inc. Earnings: FAQ's
When is Summit Therapeutics Inc.'s earnings date?
Summit Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.
How can I listen to Summit Therapeutics Inc.'s earnings conference
call?
The conference call for Summit Therapeutics Inc.'s latest earnings report can be listened to online.
How can I read Summit Therapeutics Inc.'s conference call transcript?
The conference call transcript for Summit Therapeutics Inc.'s latest earnings report can be read online.
How much profit does Summit Therapeutics Inc. generate each year?
Summit Therapeutics Inc. (:SMMT) has a recorded net income of $0. Summit Therapeutics Inc. has generated $-0.99 earnings per share over the last four quarters.
What is Summit Therapeutics Inc.'s price-to-earnings ratio?
Summit Therapeutics Inc. (:SMMT) has a price-to-earnings ratio of -66.02 and price/earnings-to-growth ratio is 3.04.